Genetic Variation (CHRNA5), Medication (Combination Nicotine Replacement Therapy vs. Varenicline) and Smoking Cessation()

OBJECTIVE: Recent evidence suggests that the efficacy of smoking cessation pharmacotherapy can vary across patients based on their genotypes. This study tests whether the coding variant rs16969968 in the CHRNA5 nicotinic receptor gene predicts the effects of combination nicotine replacement therapy...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Drug Alcohol Depend
Autori principali: Chen, Li-Shiun, Baker, Timothy B., Jorenby, Douglas, Piper, Megan, Saccone, Nancy, Johnson, Eric, Breslau, Naomi, Hatsukami, Dorothy, Carney, Robert M., Bierut, Laura J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4537319/
https://ncbi.nlm.nih.gov/pubmed/26142345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2015.06.022
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi